Latest News
WuXi LabNetwork, Science Exchange Forge Technology Partnership to Allow Rapid Access to Reagents e-Catalog
22 March 2019 - - US-based R and D services management company Science Exchange and China-based chemistry e-commerce platform WuXi LabNetwork have forged a technology partnership that will allow Science Exchange users to directly order compounds from...
Biologics by McKesson Expands Specialty Pharmacy Capabilities to Serve Patients with Rare and Complex Conditions
22 March 2019 - - US-based specialty pharmacy Biologics by McKesson is expanding its capabilities as a specialty pharmacy expert in oncology and complex conditions through a new exclusive distribution agreement, the company said.

Af...
Ligand to Receive Milestone and Royalties as Result of FDA Approval of Sage Therapeutics' Zulresso Injection Postpartum Depression Treatment
22 March 2019 - - US-based drugmaker Ligand Pharmaceuticals Inc. (NASDAQ: LGND) will receive a USD 3m milestone payment as a result of the US Food and Drug Administration's approval of Sage Therapeutics' (NASDAQ: SAGE) Zulresso (brexan...
Sanofi Starts Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis, Triggering Milestone Payment to Lead Pharma
22 March 2019 - - Dutch pharmaceutical company Lead Pharma has achieved a fourth milestone under its license and collaboration agreement with French drugmaker Sanofi (NYSE: SNY), triggering an undisclosed milestone payment, the company said.
Samsung Bioepis Releases Three-year Follow-up Data for Biosimilar Ontruzant in Early or Locally Advanced HER2-positive Breast Cancer
22 March 2019 - - South Korea-based Samsung Bioepis Co., Ltd has received findings of a three-year follow-up study comparing biosimilar Ontruzant (trastuzumab) and reference medicine trastuzumab in early or locally advanced HER2-positive breast cance...